Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo

Eur J Pharmacol. 1993 Nov 30;250(1):157-60. doi: 10.1016/0014-2999(93)90634-t.

Abstract

We investigated the role of interleukin-1 in the induction of a Ca(2+)-independent nitric oxide (NO) synthase by bacterial endotoxin in vivo. In anaesthetized rats, pretreatment with interleukin-1 receptor antagonist (interleukin-1ra; 16 mg kg-1 i.v., followed by an infusion of 2.4 mg kg-1 h-1) ameliorated the delayed hypotension and tachycardia in response to endotoxin (2 mg kg-1 i.v.). Endotoxaemia for 3 h induced a Ca(2+)-independent NO synthase activity in the lung and reduced the contractions to noradrenaline in the thoracic aorta ex vivo. Treatment with interleukin-1ra attenuated both the induction of NO synthase in the lung (by 46 +/- 5%) and the endotoxin-induced hyporeactivity to noradrenaline in the aorta. Thus, endogenous interleukin-1 contributes to the induction of NO synthase in response to endotoxin in vivo.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Oxidoreductases / biosynthesis*
  • Animals
  • Aorta, Thoracic / drug effects
  • Blood Pressure / drug effects
  • Endotoxins / toxicity*
  • Enzyme Induction / drug effects
  • Escherichia coli
  • Heart Rate / drug effects
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / pharmacology
  • Interleukin-1 / physiology*
  • Lung / enzymology
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Nitric Oxide Synthase
  • Norepinephrine / pharmacology
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / pharmacology
  • Sialoglycoproteins / pharmacology

Substances

  • Endotoxins
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Recombinant Proteins
  • Sialoglycoproteins
  • Nitric Oxide Synthase
  • Amino Acid Oxidoreductases
  • Norepinephrine